LifeStance Health Group Inc (LFST) News

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

LifeStance Reports Fourth Quarter and Full Year 2023 Results

SCOTTSDALE, Ariz., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the...

LifeStance to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on February 28, 2024

SCOTTSDALE, Ariz., Feb. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the...

Form 8-K - Current report

Form 3 - Initial statement of beneficial ownership of securities

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

LifeStance Appoints Dr. Ujjwal Ramtekkar as Chief Medical Officer

LifeStance Appoints Dr. Ujjwal Ramtekkar as Chief Medical Officer PR Newswire SCOTTSDALE, Ariz., Jan. 19, 2024...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

LifeStance Reports Third Quarter 2023 Results

SCOTTSDALE, Ariz., Nov. 08, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities